Entry Inhibitors: Efficient Means to Block Viral Infection.
J Membr Biol
; 253(5): 425-444, 2020 10.
Article
in English
| MEDLINE | ID: covidwho-734824
ABSTRACT
The emerging and re-emerging viral infections are constant threats to human health and wellbeing. Several strategies have been explored to develop vaccines against these viral diseases. The main effort in the journey of development of vaccines is to neutralize the fusion protein using antibodies. However, significant efforts have been made in discovering peptides and small molecules that inhibit the fusion between virus and host cell, thereby inhibiting the entry of viruses. This class of inhibitors is called entry inhibitors, and they are extremely efficient in reducing viral infection as the entry of the virus is considered as the first step of infection. Nevertheless, these inhibitors are highly selective for a particular virus as antibody-based vaccines. The recent COVID-19 pandemic lets us ponder to shift our attention towards broad-spectrum antiviral agents from the so-called 'one bug-one drug' approach. This review discusses peptide and small molecule-based entry inhibitors against class I, II, and III viruses and sheds light on broad-spectrum antiviral agents.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Pneumonia, Viral
/
Coronavirus Infections
/
Virus Internalization
/
Betacoronavirus
/
Membrane Fusion
Type of study:
Observational study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
J Membr Biol
Year:
2020
Document Type:
Article
Affiliation country:
S00232-020-00136-z
Similar
MEDLINE
...
LILACS
LIS